Citation Impact
Citing Papers
The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
2009 Standout
Normal and abnormal transformation of the spiral arteries during pregnancy
2006
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
1992 StandoutNature
Contraceptive failure in the United States
2011 Standout
Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis.
1993
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
The fetal inflammatory response syndrome
1998 Standout
Preliminary evidence for reduced cortisol responsivity to psychological stress in women using oral contraceptive medication
1995
Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment
2005
Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
2008
Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia
1994
Localization of the angiotensin II and its receptor subtype expression in human endometrium and identification of a novel high-affinity angiotensin II binding site.
1995
Down-Regulation of Angiopoietin-1 Expression in Menorrhagia
2002
Endometriosis
2009 Standout
Interventions for emergency contraception
2012
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Angiogenesis in health and disease
2003 Standout
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Comparative Pharmacology of Newer Progestogens
1996
The biology and pharmacology of PGD2
1988
Sex differences in HPA axis responses to stress: a review
2004 Standout
Salivary cortisol as a biomarker in stress research
2008 Standout
Obesity, weight gain, and ovarian cancer
2002
Premenstrual mood changes and maternal mental health in pregnancy and the postpartum period
1997
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Combined oral contraceptives in the treatment of polycystic ovary syndrome
2005
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Long-acting hormonal contraceptives for women
1991
Effect of four different oral contraceptives on various sex hormones and serum-binding globulins
2003
Maternal and child undernutrition: global and regional exposures and health consequences
2008 Standout
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?
2002 Standout
Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives
2002
Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review
1991
A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins
1993
The preterm parturition syndrome
2006 Standout
Predictors of Postpartum Depression
2001 Standout
Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?
2001
Intrauterine Infection and Preterm Delivery
2000 Standout
Polycystic Ovary Syndrome
2005 Standout
Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis
1995
Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?
2013 Standout
TAXI/UAS: A Molecular Switch to Control Expression of Genes In Vivo
1996 StandoutNobel
Physiology of Local Renin-Angiotensin Systems
2006 Standout
The “Great Obstetrical Syndromes” are associated with disorders of deep placentation
2010 Standout
Hormonal Etiology of Epithelial Ovarian Cancer, With a Hypothesis Concerning the Role of Androgens and Progesterone
1998
Effects of Birth Spacing on Maternal, Perinatal, Infant, and Child Health: A Systematic Review of Causal Mechanisms
2012
Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
2011 Standout
A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation
1995 Standout
Effects of long‐term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome
1995
Folate and human reproduction
2006
Endometriosis and ovarian cancer: Thoughts on shared pathophysiology
2003
Oral Contraceptives and the Management of Hyperandrogenism–Polycystic Ovary Syndrome in Adolescents
2005
Polycystic ovary syndrome
2016 Standout
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
2015 Standout
Functional somatic syndromes: one or many?
1999
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
2013 StandoutNobel
Impact of Gender, Menstrual Cycle Phase, and Oral Contraceptives on the Activity of the Hypothalamus-Pituitary-Adrenal Axis
1999 Standout
Oral contraceptive tablets containing 20 and 30 μg of ethinyl estradiol with 150 μg desogestrel: Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone
1994
The Preterm Labor Syndrome
1994
Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate
2001
PATHOGENESIS OF PRETERM LABOR AND PRETERM PREMATURE RUPTURE OF MEMBRANES ASSOCIATED WITH INTRAAMNIOTIC INFECTION
1997
Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor
1998 Standout
Epidemiology of Obstructive Sleep Apnea
2002 Standout
Endometrium and plasma hormone profile in the peri-menopause and post-menopause
1986
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
1997 StandoutScience
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Premature Labor and Intra-Amniotic Infection: Clinical Aspects and Role of the Cytokines in Diagnosis and Pathophysiology
1995
Endocrine and Paracrine Regulation of Birth at Term and Preterm*
2000 Standout
von Hippel-Lindau Disease
2006 StandoutNobel
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
The Biology of Vascular Endothelial Growth Factor
1997 Standout
Ovarian cancer statistics, 2018
2018 Standout
Interventions for enhancing medication adherence
2008 Standout
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
2000 Standout
Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
1996 StandoutNobel
Interventions for enhancing medication adherence
2014 Standout
Contragestion and Other Clinical Applications of RU 486, an Antiprogesterone at the Receptor
1989 Science
The Role of Eicosanoids in Reproduction
1999
The Biology of Chemokines and their Receptors
2000 Standout
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
1998 Standout
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.
1995 Standout
Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis.
1990
Vascular endothelial growth factor (VEGF) and its receptors
1999 Standout
Interventions for emergency contraception
2017
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
The Molecular Basis of Von Hippel-Lindau Disease
1997 StandoutNobel
Works of A.A. Haspels being referenced
The endogenous concentration of estradiol and estrone in pathological human postmenopausal endometrium
1986
Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. A preliminary report
1982
A simple strategy to detect significant premenstrual changes
1993
Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone
1990
Is premenstrual syndrome an endocrine disorder?
1993
Interception: Post-coital estrogens in 3016 women
1976
Multinational comparative clinical trial of long-acting injectable contraceptives: Norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report
1983
The endogenous concentration of estradiol and estrone in normal human postmenopausal endometrium
1984
Effects of seven low dose combined oral contraceptives on high density lipoprotein subfractions
1987
Hemostasis in Menstrual Endometrium
1982
Interception IV: Failure of mifepristone (RU 486) as a monthly contragestive, “lunarette”
1987
MORPHOLOGY OF HAEMOSTASIS IN MENSTRUAL ENDOMETRIUM
1980
Repeated vaginal administration of 15-methyl PGF2α methyl ester for termination of pregnancy in the 13th–20th week of gestation
1977
Interception III: Postcoital luteal contragestion by an antiprogestin (mifepristone, RU 486) in 62 women
1987
Interception II: Postcoital low-dose estrogens and norgestrel combination in 633 women
1985
Maternal serum folacin levels during and after normal pregnancy
1985